reengineering the art of evar - cordis...reengineering the art of evar ultra-low profile...
TRANSCRIPT
Reengineering the art of EVAR
Ultra-low profile
Customisable tri-modular design
Efficacy and durability without compromise1
Few units fit most anatomies
Reengineering the art of EVAR
Reengineering the EVAR you know
Designed for PEVAR access Perform minimally invasive PEVAR
with the ultra-low-profile 13F inner and 14F outer diameter delivery system featuring an integrated sheath introducer and state-of-the-art device compression technology2*
Crafted for simplified navigation Highly flexible, hydrophilically coated catheter
helps minimise delivery-related complications by advancing smoothly through even the most tortuous, diseased, and heavily calcified vessels2
Engineered for ease of use Use conventional delivery techniques
and fewer procedural steps to perform your procedure in less time2
Without compromising durability, the INCRAFT® AAA Stent Graft System delivers the clinical efficacy you require, as demonstrated through 5 years in the INNOVATION Trial.*
*Based on CoreLab assessments demonstrated in the INNOVATION Trial.†Study protocol defined an increase in sac diameter as an increase of ≥5 mm.
** Pratesi G , Pratesi C, Chiesa R, Coppi G, Scheinert D, Brunkwall JS, Van der Meulen S, Torsello G. The INNOVATION Trial: four-year safety and effectiveness of the INCRAFT® AAA Stent-Graft System for endovascular repair. J Cardiovasc Surg (Torino). 2017 Oct;58(5):650-657
Case demonstration: Long-term clinical success through 4 years**
Pre-
Op
1 mon
th
6 m
onth
s
12 m
onth
s
24 m
onth
s
36 m
onth
s
48 m
onth
s
Mean AAA diameters at 1, 6, 12, and 60 months post-implantation1
Proven aneurysm reduction at 5 years1* 7.15 mm average sac diameter decrease 5 5% of patients show a decrease in sac size of ≥5mm at 5-year (22/49)
No sac increase observed (0/49)†
Reengineering the art of EVAR
Ultra-low-profile delivery (13F inner and 14F outer diameter) to simplify access, navigation, and deployment.2
Customisable tri-modular design that leads to a tailored approach to EVAR.2
Efficacy and durability without compromise demonstrated through 2 years in the INNOVATION Trial.1
Few-fit-most concept requires fewer units to optimise procedure planning and inventory management.2
Talk to a Cordis representative about incorporating the INCRAFT
® AAA Stent Graft System into your EVAR programme.
Expect more from your AAA stent graft system
For healthcare professionals only. Important information: Prior to use, refer to the Instructions for Use supplied with this device for indications, contraindications, side effects, suggested procedure, warnings, and precautions.
As part of the Cordis policy of continuous product development, we reserve the right to change product specifications without prior notification.
The INCRAFT® AAA Stent Graft System should only be used by physicians and teams trained in vascular interventional techniques, including training in the use of this device. Specific training expectations are described in the Instructions for Use.
Contact your Cordis sales representative for availability and ordering. All rights reserved. CORDIS, the Cordis LOGO, INCRAFT® are trademarks or registered trademarks of Cardinal Health. EU525-1 07/14 . © Cardinal Health 2017. All Rights Reserved.. CORDIS and INCRAFT are trademarks or registered trademarks of Cordis Corporation.
References: 1. Torsello G, Brunkwall J, Scheinert D. Cordis INCRAFT™ ultra-low profile AAA stent-graft system. J Cardiovasc Surg (Torino). 2011;52(5):661-667. 2. Pratesi G. INCRAFT® AAA Stent Graft System 2-year clinical data from the INNOVATION Trial. Presented at: Charing Cross International Symposium. April, 2014. London, UK. 3. Chaikof EL, Fillinger MF, Matsumura JS. Identifying and grading factors that modify the outcome of endovascular aortic aneurysm repair. J Vasc Surg. 2002;35(5):1061-1066. 4. Kannan RY1, Salacinski HJ, Butler PE, et al. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater. 2005;74(1):570-581.
20
10
0
-10
-20
-30
DIA
ME
TE
R (
MM
)
V I S I T Month 6 Month 12 Month 24 Month 36 Month 48 Month 60
From catheter to crown, the new ultra-low profile INCRAFT® System has been designed to enhance EVAR success—including your most complex cases.2
Constructed to help reduce procedure complexity
Innovative INCRAFT® System technology, including “cap-free” trans-renal design and peri-procedure customisation, enhances the capabilities of EVAR without adding complexity2
Treatment for a broader range of patients
Demonstrated in simple and complex anatomies including patients who would have been previously excluded from EVAR, even those with small (<7 mm), diseased, and challenging vessels2,3†
*15F inner and 16F outer diameter for the 34 mm aortic bifurcate.† Ensure that femoral access vessels are adequate and compatible with
vascular access techniques and accessories used with a 14F delivery profile.
Crafted to fit your needsWith custom deployment, optimised accuracy, and proven durability, you can free yourself from other device limitations and discover the benefits of the INCRAFT® AAA Stent Graft System.
Enduring modular junction strength Durable polymer-free sealing technology
helps reduce disconnection and type III endoleaks—interlocking suture knots on the limb graft connect to the Z-stents on the inside of the aortic bifurcate legs2
Accuracy assurance Optimised placement accuracy, proximally
and distally, from the perpendicularly deployed aortic bifurcate that, with the aid of distinctive radiopaque proximal markers, can be partially repositioned prior to full deployment
Enduring modular junction strength Durable polymer-free sealing technology
helps reduce disconnection and type III endoleaks—interlocking suture knots on the limb graft connect to the Z-stents on the inside of the aortic bifurcate legs2
Proven, biodurable fabric Seamlessly woven low-porosity polyester graft is kink-resistant to help mitigate perfusion of the AAA sac2,4
Enhanced stent-graft integrity Biocompatible laser-cut nitinol stents,
which combine radial force with stent fracture resistance, are sutured to the graft to minimise micro-motion2
Advanced graft stability Mitigate migration with the unique
suprarenal fixation mechanism, featuring a flared laser-cut, trans-renal stent and integrated sharpened barbs for robust wall anchoring2
Real-time customisation In-procedure bilateral in situ adjustments
(3 cm on ipsilateral and 2 cm on contralateral side) of limb prostheses substantially improve placement accuracy and reduce the risk of inadvertent side-branch coverage2
Few-fit-most surgical graft concept2
Fewer units designed for in-procedure customisation deliver broad anatomical coverage through a wide range (3–6 mm) of oversizing—allowing you to streamline preoperative planning and inventory management.
4 aortic bifurcate diameters 19 iliac limb diameter sizes
*As demonstrated in clinical trials.**1 patient developed a late graft occlusion at day 666 treated with thrombectomy and bypass.†1 death occurred within up to 1 year, 5 within the 2-year timeframe, all non-AAA related. All deaths were CEC adjudicated and confirmed to be unrelated
to the device or to the procedure. ‡2 patients underwent re-intervention for the correction of a Type I EL at day 61 and 278.
The art of EVAR stands the test of time
100%
80%
60%
40%
20%
0%
No compromise in the durability of the AAA repair at 5 years 2*
Freedom from type I
endoleaks
Freedom from fracture
Freedom from sac enlargement
Freedom from device/procedure-
related MAE
Stent graft patency
Freedom from type III
endoleaks
Freedom from migrations
Freedom from device/procedure related events : 100% (50/50)10
0%†
100%
†
100%
100%
100%
97%
100%
100%
100%
100%
100%
97%
97%
97%
**
1 YEAR
2 YEARS
5 YEARS
56/5
6
56/5
6
56/5
6
56/5
6
56/5
6
56/5
6
56/5
6
54/5
4
54/5
4
54/5
4
54/5
4
54/5
4
54/5
4
53/5
497
.4%
100%
92.1%
97.4
%
100%
100%
97.4
%
38/3
9
50/5
0
35/3
8
38/3
9
37/3
7
38/3
8
37/3
8
Reengineering the EVAR you know
Designed for PEVAR access Perform minimally invasive PEVAR
with the ultra-low-profile 13F inner and 14F outer diameter delivery system featuring an integrated sheath introducer and state-of-the-art device compression technology2*
Crafted for simplified navigation Highly flexible, hydrophilically coated catheter
helps minimise delivery-related complications by advancing smoothly through even the most tortuous, diseased, and heavily calcified vessels2
Engineered for ease of use Use conventional delivery techniques
and fewer procedural steps to perform your procedure in less time2
Without compromising durability, the INCRAFT® AAA Stent Graft System delivers the clinical efficacy you require, as demonstrated through 5 years in the INNOVATION Trial.*
*Based on CoreLab assessments demonstrated in the INNOVATION Trial.†Study protocol defined an increase in sac diameter as an increase of ≥5 mm.
** Pratesi G , Pratesi C, Chiesa R, Coppi G, Scheinert D, Brunkwall JS, Van der Meulen S, Torsello G. The INNOVATION Trial: four-year safety and effectiveness of the INCRAFT® AAA Stent-Graft System for endovascular repair. J Cardiovasc Surg (Torino). 2017 Oct;58(5):650-657
Case demonstration: Long-term clinical success through 4 years**
Pre-
Op
1 mon
th
6 m
onth
s
12 m
onth
s
24 m
onth
s
36 m
onth
s
48 m
onth
s
Mean AAA diameters at 1, 6, 12, and 60 months post-implantation1
Proven aneurysm reduction at 5 years1* 7.15 mm average sac diameter decrease 55% of patients show a decrease in sac size of ≥5mm at 5-year (22/49)
No sac increase observed (0/49)†
Reengineering the art of EVAR
Ultra-low-profile delivery (13F inner and 14F outer diameter) to simplify access, navigation, and deployment.2
Customisable tri-modular design that leads to a tailored approach to EVAR.2
Efficacy and durability without compromise demonstrated through 2 years in the INNOVATION Trial.1
Few-fit-most concept requires fewer units to optimise procedure planning and inventory management.2
Talk to a Cordis representative about incorporating the INCRAFT
® AAA Stent Graft System into your EVAR programme.
Expect more from your AAA stent graft system
For healthcare professionals only. Important information: Prior to use, refer to the Instructions for Use supplied with this device for indications, contraindications, side effects, suggested procedure, warnings, and precautions.
As part of the Cordis policy of continuous product development, we reserve the right to change product specifications without prior notification.
The INCRAFT® AAA Stent Graft System should only be used by physicians and teams trained in vascular interventional techniques, including training in the use of this device. Specific training expectations are described in the Instructions for Use.
Contact your Cordis sales representative for availability and ordering. All rights reserved. CORDIS, the Cordis LOGO, INCRAFT® are trademarks or registered trademarks of Cardinal Health. EU525-1 07/14 . © Cardinal Health 2017. All Rights Reserved.. CORDIS and INCRAFT are trademarks or registered trademarks of Cordis Corporation.
References: 1. Torsello G, Brunkwall J, Scheinert D. Cordis INCRAFT™ ultra-low profile AAA stent-graft system. J Cardiovasc Surg (Torino). 2011;52(5):661-667. 2. Pratesi G. INCRAFT® AAA Stent Graft System 2-year clinical data from the INNOVATION Trial. Presented at: Charing Cross International Symposium. April, 2014. London, UK. 3. Chaikof EL, Fillinger MF, Matsumura JS. Identifying and grading factors that modify the outcome of endovascular aortic aneurysm repair. J Vasc Surg. 2002;35(5):1061-1066. 4. Kannan RY1, Salacinski HJ, Butler PE, et al. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater. 2005;74(1):570-581.
20
10
0
-10
-20
-30
DIA
ME
TE
R (
MM
)
V I S I T Month 6 Month 12 Month 24 Month 36 Month 48 Month 60
Reengineering the EVAR you know
Designed for PEVAR access Perform minimally invasive PEVAR
with the ultra-low-profile 13F inner and 14F outer diameter delivery system featuring an integrated sheath introducer and state-of-the-art device compression technology2*
Crafted for simplified navigation Highly flexible, hydrophilically coated catheter
helps minimise delivery-related complications by advancing smoothly through even the most tortuous, diseased, and heavily calcified vessels2
Engineered for ease of use Use conventional delivery techniques
and fewer procedural steps to perform your procedure in less time2
Without compromising durability, the INCRAFT®
AAA Stent Graft System delivers the clinical efficacy you require, as demonstrated through 5 years in the INNOVATION Trial.*
*Based on CoreLab assessments demonstrated in the INNOVATION Trial.†Study protocol defined an increase in sac diameter as an increase of ≥5 mm.
** Pratesi G , Pratesi C, Chiesa R, Coppi G, Scheinert D, Brunkwall JS, Van der Meulen S, Torsello G. The INNOVATION Trial: four-year safety and effectiveness of the INCRAFT® AAA Stent-Graft System for endovascular repair. J Cardiovasc Surg (Torino). 2017 Oct;58(5):650-657
Case demonstration: Long-term clinical success through 4 years**
Pre-Op
1 month
6 months
12 months
24 months
36 months
48 months
Mean AAA diameters at 1, 6, 12, and 60 months post-implantation1
Proven aneurysm reduction at 5 years1* 7.15 mm average sac diameter decrease 55% of patients show a decrease in sac size of ≥5mm at 5-year (22/49)
No sac increase observed (0/49)†
Reengineering the art of EVAR
Ultra-low-profile delivery (13F inner and 14F outer diameter) to simplify access, navigation, and deployment.1
Customisable tri-modular design that leads to a tailored approach to EVAR.1
Efficacy and durability without compromise demonstrated through 5 years in the INNOVATION Trial.2
Few-fit-most concept requires fewer units to optimise procedure planning and inventory management.1
Talk to a Cordis representative about incorporating the INCRAFT® AAA Stent Graft System into your EVAR programme.
Expect more from your AAA stent graft system
For healthcare professionals only. Important information: Prior to use, refer to the Instructions for Use supplied with this device for indications, contraindications, side effects, suggested procedure, warnings, and precautions.
As part of the Cordis policy of continuous product development, we reserve the right to change product specifications without prior notification.
The INCRAFT® AAA Stent Graft System should only be used by physicians and teams trained in vascular interventional techniques, including training in the use of this device. Specific training expectations are described in the Instructions for Use. As part of its continuous product development policy, Cordis reserves the right to change product specifications without prior notification.
Contact your Cordis sales representative for availability and ordering. © Cardinal Health 2017. All Rights Reserved. CORDIS, the Cordis LOGO, and INCRAFT are trademarks of Cardinal Health and may be registered in the US and/or in other countries.100503409 10/17
References: 1. Torsello G, Brunkwall J, Scheinert D. Cordis INCRAFT™ ultra-low profile AAA stent-graft system. J Cardiovasc Surg (Torino). 2011;52(5):661-667. 2. Pratesi G. INCRAFT® AAA Stent Graft System 2-year clinical data from the INNOVATION Trial. Presented at: Charing Cross International Symposium. April, 2014. London, UK. 3. Chaikof EL, Fillinger MF, Matsumura JS. Identifying and grading factors that modify the outcome of endovascular aortic aneurysm repair. J Vasc Surg. 2002;35(5):1061-1066. 4. Kannan RY1, Salacinski HJ, Butler PE, et al. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater. 2005;74(1):570-581.
20
10
0
-10
-20
-30
DIA
ME
TE
R (M
M)
VISIT Month 6 Month 12 Month 24 Month 36 Month 48 Month 60
Product Ordering Information
Order
For ordering information, please contact your Cordis representative.
Aort
ic B
ifur
cate
AB2298
AB2698
AB3098
AB3498
ProductCode
22
26
30
34
AB Size(mm)
17.0 – 19.9
20.0 – 22.9
23.0 – 26.9
27.0 – 31.0
TreatmentRange(mm)
13
13
13
15
DeliverySystem
ID (F)
14
14
14
16
DeliverySystemOD (F)
94
94
94
94
IpsiLength
(mm)
86
86
86
86
ContraLength
(mm)
Iliac
Lim
b /
Lim
b Ex
tens
ion
ProductCode
IL1008
IL1010
IL1012
IL1014
IL1308
IL1310
IL1312
IL1314
IL1608
IL1610
IL1612
IL1614
IL2008
IL2010
IL2012
IL2014
IL2410
IL2412
IL2414
IL Size(mm)
10
10
10
10
13
13
13
13
16
16
16
16
20
20
20
20
24
24
24
TreatmentRange(mm)
7.0 – 8.9
7.0 – 8.9
7.0 – 8.9
7.0 – 8.9
9.0 – 10.9
9.0 – 10.9
9.0 – 10.9
9.0 – 10.9
11.0 – 13.9
11.0 – 13.9
11.0 – 13.9
11.0 – 13.9
14.0 – 17.9
14.0 – 17.9
14.0 – 17.9
14.0 – 17.9
18.0 – 22.0
18.0 – 22.0
18.0 – 22.0
ILLength
(mm)
82
101
120
138
82
101
120
138
82
101
120
138
82
101
120
138
101
120
138
DeliverySystemOD (F)
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
13
13
13
IpsiLength
(mm)
128 – 156
147 – 175
166 – 194
184 – 212
128 – 156
147 – 175
166 – 194
184 – 212
128 – 156
147 – 175
166 – 194
184 – 212
128 – 156
147 – 175
166 – 194
184 – 212
147 – 175
166 – 194
184 – 212
ContraLength
(mm)
128 – 147
147 – 166
166 – 185
184 – 203
128 – 147
147 – 166
166 – 185
184 – 203
128 – 147
147 – 166
166 – 185
184 – 203
128 – 147
147 – 166
166 – 185
184 – 203
147 – 166
166 – 185
184 – 203
Product Portfolio
Order
Aort
ic E
xten
sion
AE2204AE2604AE3004
AE3404
Product Code
222630
34
Aortic Extension
Diameter (mm)
17.0 – 19.920.0 – 22.923.0 – 26.9
27.0 – 31.0
Treatment Range(mm)
131313
15
Delivery System
ID (F)
141414
16
Delivery System OD (F)
424242
42
Length(mm)